CLEAR is a proof-of-principle study, according to Dr Philippe Ritter (Centre Hospitalier Universitaire de Bordeaux), who presented the results at Cardiostim 2010 last week. The results show that ...
BOSTON--(BUSINESS WIRE)-- Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today at Heart Rhythm 2012, the ...
Biventricular pacing has two primary (electrical) effects on the heart; the first effect is the change in atrioventricular (A-V) interval, which influences the timing of atrial contraction relative to ...
The SMART-AV trial has found no benefit of programmed atrioventricular (AV) delay being optimized on the basis of echocardiography or an electrocardiographic algorithm (SmartDelay ®, Cardiac ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
St. Jude Medical today announced U.S. Food and Drug Administration (FDA) approval of its first radiofrequency (RF) wireless devices to treat patients with heart failure and with potentially lethal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback